FIELD: medicine.
SUBSTANCE: application of a peptide of the formula Thr-Lys-Pro-Arg-Pro-Gly-Pro (selank) as a hepatoprotective agent is proposed. The method of the invention comprises administration of a drug based on the heptapeptide of the general formula Thr-Lys-Pro-Arg-Pro-Gly-Pro (selank) by application to the mucosa.
EFFECT: application of the inventions allows to reliably reduce lethality, cytolysis level, metabolic disturbances, increase the activity of the detoxification process, prevent the development of significant changes in liver morphology and cytoarchitectonics.
2 cl, 9 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANC) HEPATOPROTECTIVE FOR EXPOSURE IN ACUTE IMMOBILISATION STRESS | 2015 |
|
RU2582963C1 |
| APPLICATION OF THR-LYS-PRO-ARG-PRO-GLY-PRO PEPTIDE (SELANK) FOR HEPATOPROTECTIVE IMPACT IN CHRONIC EMOTIONAL-PAIN STRESS | 2016 |
|
RU2629832C1 |
| USE OF THE PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANK) TO INCREASE BODY RESISTANCE TO ACUTE HYPOTHERMIA | 2019 |
|
RU2709503C1 |
| APPLICATION OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANG) FOR DYSBIOSIS CORRECTION UNDER CHRONIC IMMOBILIZATION STRESS | 2018 |
|
RU2681217C1 |
| METHOD FOR PREVENTING AND TREATING ULCERS OF GASTRO-INTESTINAL TRACT | 2003 |
|
RU2252779C1 |
| AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
| ADMINISTRATION OF Arg-Pro-Gly-Pro PEPTIDE AS ANTIVIRAL AGENT FOR ANIMALS | 2009 |
|
RU2414235C1 |
| ORAL PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES | 2010 |
|
RU2445965C2 |
| COMPOSITION AND USING COMPOSITION FOR PREPARING DRUG HAVING HEPATOPROTECTIVE ACTIVITY | 2012 |
|
RU2485970C1 |
